Tags

Type your tag names separated by a space and hit enter

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.
Cell Res. 2020 10; 30(10):932-935.CR

Authors+Show Affiliations

Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA.Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA. sjiang@nybc.org.Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, 10065, USA. ldu@nybc.org.

Pub Type(s)

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

32759966

Citation

Tai, Wanbo, et al. "A Novel Receptor-binding Domain (RBD)-based mRNA Vaccine Against SARS-CoV-2." Cell Research, vol. 30, no. 10, 2020, pp. 932-935.
Tai W, Zhang X, Drelich A, et al. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2. Cell Res. 2020;30(10):932-935.
Tai, W., Zhang, X., Drelich, A., Shi, J., Hsu, J. C., Luchsinger, L., Hillyer, C. D., Tseng, C. K., Jiang, S., & Du, L. (2020). A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2. Cell Research, 30(10), 932-935. https://doi.org/10.1038/s41422-020-0387-5
Tai W, et al. A Novel Receptor-binding Domain (RBD)-based mRNA Vaccine Against SARS-CoV-2. Cell Res. 2020;30(10):932-935. PubMed PMID: 32759966.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2. AU - Tai,Wanbo, AU - Zhang,Xiujuan, AU - Drelich,Aleksandra, AU - Shi,Juan, AU - Hsu,Jason C, AU - Luchsinger,Larry, AU - Hillyer,Christopher D, AU - Tseng,Chien-Te K, AU - Jiang,Shibo, AU - Du,Lanying, Y1 - 2020/08/05/ PY - 2020/06/09/received PY - 2020/07/23/accepted PY - 2020/8/8/pubmed PY - 2020/10/21/medline PY - 2020/8/8/entrez SP - 932 EP - 935 JF - Cell research JO - Cell Res VL - 30 IS - 10 SN - 1748-7838 UR - https://www.unboundmedicine.com/medline/citation/32759966/A_novel_receptor_binding_domain__RBD__based_mRNA_vaccine_against_SARS_CoV_2_ L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32759966/ DB - PRIME DP - Unbound Medicine ER -